2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 31.111 | 56.695 | 43.293 | 22.442 | 8.024 | 3.204 |
Total Income - EUR | - | - | - | - | 31.113 | 56.889 | 43.339 | 23.462 | 8.040 | 3.205 |
Total Expenses - EUR | - | - | - | - | 1.341 | 4.889 | 7.478 | 22.723 | 11.540 | 12.870 |
Gross Profit/Loss - EUR | - | - | - | - | 29.772 | 52.000 | 35.861 | 740 | -3.501 | -9.665 |
Net Profit/Loss - EUR | - | - | - | - | 28.839 | 50.294 | 34.601 | 104 | -3.741 | -9.665 |
Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Anghel&Bufano Med S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | - | - | - | - | 30.841 | 86.756 | 125.254 | 109.499 | 102.737 | 96.136 |
Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 537 |
Receivables | - | - | - | - | 7.409 | 18.257 | 58.336 | 108.894 | 101.391 | 95.539 |
Cash | - | - | - | - | 23.432 | 68.499 | 66.918 | 605 | 1.346 | 61 |
Shareholders Funds | - | - | - | - | 28.882 | 78.616 | 111.727 | 109.110 | 105.708 | 95.324 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 1.959 | 8.140 | 13.527 | 389 | 0 | 2.836 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 801 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year |
8690
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Anghel&Bufano Med S.r.l.